Peginterferon alfa-2a (Peg-IFN)

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis C InfectionHepatitis C, Chronic

Phase 2

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

CompletedNCT01011166

Merck Sharp & Dohme LLCChronic Hepatitis C Infection

Start: 2009-11-30End: 2010-07-31Updated: 2015-04-23

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)

CompletedNCT01371604

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2011-07-31End: 2014-10-31Updated: 2015-02-06